FDA approves two therapies to treat IBS-D

The U.S. Food and Drug Administration has approved Viberzi (eluxadoline) and Xifaxan (rifaximin), two new treatments, manufactured by two different companies, for irritable bowel syndrome with diarrhea (IBS-D) in adult men and women. According to…

Published

It’s time to support older people in giving up smoking

New research published online in the British Journal of Psychiatry suggests that supporting older people with mental ill-health to give up smoking has positive health benefits and will not, nam chaga chua benh aids as…

Published

Hello world!

Welcome to BCZ. This is your first post. Edit or delete it, then start blogging!

Published